Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Intensive Care Units | 60 | 2021 | 3679 | 3.210 |
Why?
|
Critical Care | 30 | 2020 | 2647 | 2.400 |
Why?
|
Critical Illness | 34 | 2020 | 2670 | 2.300 |
Why?
|
Hospital Mortality | 32 | 2020 | 5317 | 2.180 |
Why?
|
Patient Admission | 10 | 2020 | 1380 | 1.910 |
Why?
|
Medical Informatics | 9 | 2020 | 745 | 1.760 |
Why?
|
Artificial Intelligence | 11 | 2020 | 2214 | 1.570 |
Why?
|
Sepsis | 18 | 2020 | 2593 | 1.550 |
Why?
|
Respiration, Artificial | 11 | 2019 | 2569 | 1.370 |
Why?
|
Delivery of Health Care | 10 | 2020 | 5319 | 1.290 |
Why?
|
Databases, Factual | 26 | 2020 | 7729 | 1.220 |
Why?
|
Biomedical Research | 9 | 2020 | 3309 | 1.020 |
Why?
|
Triage | 3 | 2020 | 976 | 0.900 |
Why?
|
Information Dissemination | 3 | 2020 | 1099 | 0.770 |
Why?
|
Electronic Health Records | 9 | 2020 | 4468 | 0.740 |
Why?
|
Data Mining | 5 | 2018 | 537 | 0.710 |
Why?
|
Minority Health | 1 | 2020 | 87 | 0.690 |
Why?
|
Public Health Informatics | 1 | 2020 | 110 | 0.680 |
Why?
|
Humanities | 1 | 2019 | 53 | 0.670 |
Why?
|
Appointments and Schedules | 2 | 2020 | 417 | 0.670 |
Why?
|
Length of Stay | 10 | 2019 | 6309 | 0.640 |
Why?
|
Third-Party Consent | 1 | 2018 | 64 | 0.630 |
Why?
|
Coronavirus | 1 | 2020 | 158 | 0.600 |
Why?
|
Monitoring, Physiologic | 5 | 2018 | 1738 | 0.600 |
Why?
|
Central Venous Pressure | 2 | 2016 | 78 | 0.590 |
Why?
|
Metoprolol | 1 | 2017 | 93 | 0.590 |
Why?
|
Diltiazem | 1 | 2017 | 133 | 0.590 |
Why?
|
Cooperative Behavior | 6 | 2018 | 1504 | 0.560 |
Why?
|
Patient Transfer | 3 | 2018 | 761 | 0.560 |
Why?
|
Natural Language Processing | 3 | 2020 | 1041 | 0.550 |
Why?
|
Magnesium | 3 | 2015 | 813 | 0.550 |
Why?
|
Forecasting | 3 | 2020 | 2951 | 0.550 |
Why?
|
Zinc | 1 | 2020 | 684 | 0.540 |
Why?
|
Amiodarone | 1 | 2017 | 212 | 0.540 |
Why?
|
Hospitals, Teaching | 6 | 2018 | 1179 | 0.530 |
Why?
|
Peer Review, Research | 2 | 2019 | 329 | 0.530 |
Why?
|
Advanced Cardiac Life Support | 1 | 2015 | 70 | 0.530 |
Why?
|
Decision Support Systems, Clinical | 5 | 2020 | 1164 | 0.520 |
Why?
|
Humans | 149 | 2021 | 744343 | 0.510 |
Why?
|
Edema | 2 | 2016 | 789 | 0.510 |
Why?
|
Aged | 69 | 2020 | 163280 | 0.510 |
Why?
|
Retrospective Studies | 52 | 2020 | 77449 | 0.510 |
Why?
|
Information Management | 1 | 2014 | 101 | 0.480 |
Why?
|
Drug Dosage Calculations | 1 | 2014 | 114 | 0.470 |
Why?
|
Deep Sedation | 1 | 2015 | 121 | 0.460 |
Why?
|
Vasoconstrictor Agents | 7 | 2019 | 642 | 0.460 |
Why?
|
Palliative Care | 5 | 2017 | 3493 | 0.460 |
Why?
|
Aged, 80 and over | 38 | 2020 | 57776 | 0.450 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2016 | 367 | 0.450 |
Why?
|
Male | 90 | 2020 | 350118 | 0.440 |
Why?
|
Hypoglycemia | 1 | 2020 | 861 | 0.440 |
Why?
|
Knowledge | 1 | 2014 | 181 | 0.440 |
Why?
|
Siblings | 1 | 2017 | 854 | 0.440 |
Why?
|
Norepinephrine | 2 | 2018 | 909 | 0.430 |
Why?
|
Telemedicine | 7 | 2019 | 2872 | 0.430 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 3047 | 0.430 |
Why?
|
Middle Aged | 69 | 2020 | 213383 | 0.430 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 3 | 2009 | 35 | 0.420 |
Why?
|
Learning | 3 | 2018 | 1713 | 0.420 |
Why?
|
Catheterization, Peripheral | 1 | 2015 | 345 | 0.420 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1405 | 0.410 |
Why?
|
Female | 89 | 2020 | 380194 | 0.410 |
Why?
|
Urban Population | 1 | 2020 | 2021 | 0.410 |
Why?
|
Kidney Failure, Chronic | 3 | 2020 | 2538 | 0.400 |
Why?
|
New Zealand | 7 | 2013 | 355 | 0.400 |
Why?
|
Logistic Models | 13 | 2020 | 13408 | 0.400 |
Why?
|
Hyperglycemia | 1 | 2020 | 1373 | 0.390 |
Why?
|
Influenza, Human | 4 | 2017 | 1479 | 0.390 |
Why?
|
Severity of Illness Index | 18 | 2020 | 15540 | 0.390 |
Why?
|
Capacity Building | 1 | 2013 | 248 | 0.390 |
Why?
|
Terminal Care | 4 | 2019 | 1694 | 0.390 |
Why?
|
Resuscitation Orders | 4 | 2020 | 269 | 0.380 |
Why?
|
Medicine | 1 | 2019 | 946 | 0.380 |
Why?
|
Software | 5 | 2018 | 4443 | 0.380 |
Why?
|
Conscious Sedation | 1 | 2015 | 528 | 0.370 |
Why?
|
Portugal | 2 | 2020 | 87 | 0.370 |
Why?
|
Troponin | 1 | 2014 | 524 | 0.360 |
Why?
|
Mortality | 2 | 2019 | 2864 | 0.360 |
Why?
|
Home Care Services | 1 | 2016 | 606 | 0.360 |
Why?
|
Algorithms | 12 | 2020 | 13881 | 0.350 |
Why?
|
Erythrocyte Transfusion | 1 | 2014 | 565 | 0.350 |
Why?
|
Voluntary Programs | 1 | 2009 | 42 | 0.350 |
Why?
|
Coronary Artery Bypass | 1 | 2019 | 2289 | 0.350 |
Why?
|
Atrial Fibrillation | 3 | 2018 | 5034 | 0.340 |
Why?
|
Hospitalization | 9 | 2021 | 10262 | 0.330 |
Why?
|
Fluid Therapy | 2 | 2013 | 593 | 0.330 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2016 | 1018 | 0.330 |
Why?
|
Language | 1 | 2018 | 1471 | 0.320 |
Why?
|
Patient Preference | 1 | 2015 | 890 | 0.320 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2015 | 980 | 0.320 |
Why?
|
Medical Records Systems, Computerized | 1 | 2014 | 1205 | 0.310 |
Why?
|
Pandemics | 4 | 2020 | 8388 | 0.310 |
Why?
|
Hypoglycemic Agents | 1 | 2020 | 2872 | 0.310 |
Why?
|
Vaccination | 3 | 2009 | 3278 | 0.310 |
Why?
|
Hemothorax | 1 | 2007 | 60 | 0.300 |
Why?
|
Mammary Arteries | 1 | 2007 | 70 | 0.300 |
Why?
|
Respiratory Insufficiency | 1 | 2015 | 1199 | 0.290 |
Why?
|
Heparin | 1 | 2014 | 1637 | 0.290 |
Why?
|
Quality of Health Care | 4 | 2018 | 4371 | 0.290 |
Why?
|
Public Health | 1 | 2020 | 2603 | 0.290 |
Why?
|
Acute Kidney Injury | 6 | 2016 | 1972 | 0.290 |
Why?
|
Risk Assessment | 10 | 2020 | 23338 | 0.280 |
Why?
|
Echocardiography | 2 | 2018 | 5102 | 0.280 |
Why?
|
United States | 25 | 2020 | 69872 | 0.270 |
Why?
|
Blood Glucose | 1 | 2020 | 6256 | 0.270 |
Why?
|
Liver Cirrhosis | 3 | 2020 | 1863 | 0.270 |
Why?
|
Proton Pump Inhibitors | 3 | 2016 | 526 | 0.270 |
Why?
|
Stroke Volume | 2 | 2015 | 5007 | 0.260 |
Why?
|
Cross Infection | 2 | 2011 | 1416 | 0.260 |
Why?
|
Insulin | 1 | 2020 | 6580 | 0.260 |
Why?
|
Insurance Coverage | 1 | 2017 | 1901 | 0.260 |
Why?
|
Data Collection | 1 | 2015 | 3341 | 0.260 |
Why?
|
Age Factors | 8 | 2018 | 18370 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3133 | 0.260 |
Why?
|
Pheochromocytoma | 1 | 2007 | 337 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3240 | 0.260 |
Why?
|
Carbon Dioxide | 5 | 2010 | 1150 | 0.250 |
Why?
|
Water-Electrolyte Imbalance | 2 | 2017 | 113 | 0.250 |
Why?
|
Propensity Score | 3 | 2018 | 1781 | 0.250 |
Why?
|
Hypotension | 3 | 2016 | 884 | 0.250 |
Why?
|
Referral and Consultation | 4 | 2017 | 3528 | 0.250 |
Why?
|
Internet | 2 | 2016 | 3064 | 0.250 |
Why?
|
Ozone | 2 | 2018 | 469 | 0.240 |
Why?
|
Insurance, Health | 1 | 2017 | 2494 | 0.240 |
Why?
|
Models, Statistical | 4 | 2020 | 5102 | 0.240 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2015 | 2073 | 0.240 |
Why?
|
Risk Factors | 24 | 2020 | 72290 | 0.240 |
Why?
|
Heart Failure | 6 | 2018 | 10900 | 0.230 |
Why?
|
Liver Failure | 2 | 2017 | 241 | 0.230 |
Why?
|
Influenza Vaccines | 2 | 2008 | 738 | 0.230 |
Why?
|
Endovascular Procedures | 1 | 2016 | 1979 | 0.220 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2861 | 0.220 |
Why?
|
Pneumonia | 4 | 2021 | 2133 | 0.220 |
Why?
|
Adult | 40 | 2020 | 214055 | 0.210 |
Why?
|
Aneurysm, Ruptured | 1 | 2007 | 452 | 0.210 |
Why?
|
Health Personnel | 3 | 2018 | 3218 | 0.210 |
Why?
|
Neurofibromatosis 1 | 1 | 2007 | 569 | 0.210 |
Why?
|
Interdisciplinary Communication | 3 | 2018 | 950 | 0.210 |
Why?
|
Longitudinal Studies | 8 | 2020 | 13989 | 0.210 |
Why?
|
Patient Readmission | 4 | 2020 | 3114 | 0.210 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2007 | 740 | 0.200 |
Why?
|
Healthcare Disparities | 2 | 2018 | 3158 | 0.200 |
Why?
|
Survival Rate | 5 | 2020 | 12788 | 0.200 |
Why?
|
Communication | 1 | 2015 | 3749 | 0.200 |
Why?
|
Odds Ratio | 8 | 2020 | 9849 | 0.200 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2017 | 451 | 0.200 |
Why?
|
Access to Information | 3 | 2020 | 320 | 0.200 |
Why?
|
Sodium | 2 | 2017 | 1623 | 0.190 |
Why?
|
ROC Curve | 5 | 2020 | 3527 | 0.190 |
Why?
|
Health Services Accessibility | 3 | 2018 | 5137 | 0.190 |
Why?
|
Blood Pressure | 5 | 2018 | 8554 | 0.190 |
Why?
|
Hypercapnia | 4 | 2010 | 260 | 0.190 |
Why?
|
Occupational Diseases | 1 | 2009 | 1471 | 0.190 |
Why?
|
Wounds and Injuries | 1 | 2013 | 2400 | 0.190 |
Why?
|
Alcohol Drinking | 1 | 2013 | 3966 | 0.180 |
Why?
|
Phenotype | 1 | 2018 | 16365 | 0.180 |
Why?
|
Prognosis | 12 | 2020 | 29063 | 0.180 |
Why?
|
Nurses | 1 | 2009 | 2461 | 0.170 |
Why?
|
Body Surface Area | 1 | 2019 | 198 | 0.170 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2020 | 1130 | 0.170 |
Why?
|
Cardiac Complexes, Premature | 1 | 2018 | 64 | 0.170 |
Why?
|
Cerebrovascular Circulation | 5 | 2010 | 2731 | 0.170 |
Why?
|
Arrhythmias, Cardiac | 3 | 2019 | 2268 | 0.170 |
Why?
|
Anticoagulants | 1 | 2014 | 4599 | 0.170 |
Why?
|
Antidiuretic Agents | 1 | 2018 | 24 | 0.170 |
Why?
|
Treatment Outcome | 7 | 2020 | 63114 | 0.160 |
Why?
|
Physicians | 1 | 2017 | 4567 | 0.160 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2020 | 96 | 0.160 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7279 | 0.160 |
Why?
|
Reproducibility of Results | 6 | 2019 | 19905 | 0.160 |
Why?
|
APACHE | 1 | 2019 | 277 | 0.160 |
Why?
|
Time Factors | 13 | 2020 | 40075 | 0.160 |
Why?
|
Candidiasis | 1 | 2011 | 366 | 0.160 |
Why?
|
Bed Occupancy | 1 | 2018 | 41 | 0.160 |
Why?
|
Hypokalemia | 1 | 2019 | 153 | 0.160 |
Why?
|
Cohort Studies | 15 | 2020 | 40561 | 0.160 |
Why?
|
Abdomen | 1 | 2014 | 1118 | 0.160 |
Why?
|
Models, Theoretical | 5 | 2017 | 3589 | 0.160 |
Why?
|
Extensively Drug-Resistant Tuberculosis | 1 | 2018 | 92 | 0.160 |
Why?
|
Computer Security | 1 | 2020 | 262 | 0.160 |
Why?
|
Esophageal and Gastric Varices | 1 | 2020 | 207 | 0.150 |
Why?
|
Stroke | 1 | 2020 | 9981 | 0.150 |
Why?
|
Embolism, Amniotic Fluid | 1 | 2017 | 19 | 0.150 |
Why?
|
Renal Dialysis | 2 | 2017 | 1786 | 0.150 |
Why?
|
Postoperative Period | 2 | 2019 | 1842 | 0.150 |
Why?
|
Disease-Free Survival | 2 | 2018 | 6895 | 0.150 |
Why?
|
Puerperal Infection | 1 | 2017 | 46 | 0.150 |
Why?
|
Information Storage and Retrieval | 2 | 2016 | 824 | 0.150 |
Why?
|
Hypocapnia | 4 | 2010 | 34 | 0.140 |
Why?
|
Income | 2 | 2017 | 1913 | 0.140 |
Why?
|
Vasopressins | 1 | 2018 | 370 | 0.140 |
Why?
|
Boston | 6 | 2019 | 9313 | 0.140 |
Why?
|
Health Facility Size | 1 | 2016 | 64 | 0.140 |
Why?
|
Histamine H2 Antagonists | 2 | 2015 | 165 | 0.140 |
Why?
|
Dialysis Solutions | 1 | 2016 | 39 | 0.140 |
Why?
|
Blood Gas Analysis | 2 | 2015 | 383 | 0.140 |
Why?
|
Water-Electrolyte Balance | 2 | 2015 | 346 | 0.140 |
Why?
|
Databases as Topic | 2 | 2016 | 475 | 0.140 |
Why?
|
Withholding Treatment | 2 | 2019 | 599 | 0.140 |
Why?
|
Regression Analysis | 2 | 2018 | 6459 | 0.140 |
Why?
|
Hospitals | 2 | 2020 | 3952 | 0.140 |
Why?
|
Body Weight | 2 | 2019 | 4669 | 0.140 |
Why?
|
Systole | 1 | 2018 | 958 | 0.140 |
Why?
|
Particulate Matter | 2 | 2018 | 2530 | 0.140 |
Why?
|
Renal Replacement Therapy | 1 | 2018 | 257 | 0.140 |
Why?
|
Bacterial Infections | 1 | 2014 | 1401 | 0.130 |
Why?
|
Tidal Volume | 1 | 2018 | 490 | 0.130 |
Why?
|
Fuzzy Logic | 1 | 2015 | 56 | 0.130 |
Why?
|
Patient Discharge | 2 | 2018 | 3313 | 0.130 |
Why?
|
Community Health Services | 2 | 2018 | 650 | 0.130 |
Why?
|
Lactic Acid | 2 | 2018 | 1133 | 0.130 |
Why?
|
Family Characteristics | 1 | 2020 | 1000 | 0.130 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12245 | 0.130 |
Why?
|
Health Services Research | 2 | 2020 | 1836 | 0.130 |
Why?
|
Publication Bias | 1 | 2016 | 162 | 0.130 |
Why?
|
After-Hours Care | 1 | 2016 | 102 | 0.130 |
Why?
|
Potassium | 1 | 2019 | 1336 | 0.130 |
Why?
|
Hospitals, Rural | 1 | 2016 | 172 | 0.130 |
Why?
|
Middle Cerebral Artery | 4 | 2010 | 264 | 0.120 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 789 | 0.120 |
Why?
|
Injury Severity Score | 1 | 2018 | 1014 | 0.120 |
Why?
|
Hospitals, Urban | 1 | 2016 | 499 | 0.120 |
Why?
|
Decision Support Techniques | 2 | 2016 | 1956 | 0.120 |
Why?
|
National Health Programs | 1 | 2018 | 445 | 0.120 |
Why?
|
Health Services Misuse | 1 | 2016 | 243 | 0.120 |
Why?
|
Ophthalmology | 1 | 2020 | 508 | 0.120 |
Why?
|
Magnesium Deficiency | 1 | 2014 | 47 | 0.120 |
Why?
|
China | 1 | 2020 | 2248 | 0.120 |
Why?
|
Air Pollution | 2 | 2018 | 2286 | 0.120 |
Why?
|
Body Mass Index | 4 | 2019 | 12720 | 0.120 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2015 | 135 | 0.120 |
Why?
|
Partial Thromboplastin Time | 1 | 2014 | 206 | 0.120 |
Why?
|
Problem Solving | 1 | 2016 | 440 | 0.120 |
Why?
|
Area Under Curve | 4 | 2018 | 1654 | 0.110 |
Why?
|
Pulmonary Edema | 1 | 2016 | 414 | 0.110 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2018 | 581 | 0.110 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 426 | 0.110 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2017 | 1155 | 0.110 |
Why?
|
Acidosis, Lactic | 1 | 2014 | 142 | 0.110 |
Why?
|
Treatment Failure | 1 | 2018 | 2618 | 0.110 |
Why?
|
Lymphocyte Count | 1 | 2015 | 793 | 0.110 |
Why?
|
Sex Factors | 3 | 2018 | 10397 | 0.110 |
Why?
|
Health Services | 1 | 2018 | 758 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 643 | 0.110 |
Why?
|
Review Literature as Topic | 1 | 2014 | 336 | 0.110 |
Why?
|
Minority Groups | 1 | 2020 | 1223 | 0.110 |
Why?
|
Feedback, Physiological | 1 | 2015 | 479 | 0.100 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2016 | 501 | 0.100 |
Why?
|
Pain Measurement | 2 | 2019 | 3420 | 0.100 |
Why?
|
Informed Consent | 1 | 2018 | 995 | 0.100 |
Why?
|
Hemodynamics | 3 | 2018 | 4199 | 0.100 |
Why?
|
Erythrocyte Indices | 1 | 2012 | 146 | 0.100 |
Why?
|
Unemployment | 1 | 2013 | 214 | 0.100 |
Why?
|
Fibrosis | 1 | 2018 | 2029 | 0.100 |
Why?
|
Obesity | 4 | 2019 | 12745 | 0.100 |
Why?
|
Attitude of Health Personnel | 3 | 2017 | 3843 | 0.100 |
Why?
|
Comorbidity | 6 | 2018 | 10388 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 804 | 0.100 |
Why?
|
Emergency Service, Hospital | 2 | 2020 | 7659 | 0.090 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1772 | 0.090 |
Why?
|
Antitubercular Agents | 1 | 2018 | 1320 | 0.090 |
Why?
|
Patient Care Team | 2 | 2018 | 2531 | 0.090 |
Why?
|
Heart Arrest | 1 | 2020 | 1470 | 0.090 |
Why?
|
Editorial Policies | 1 | 2014 | 451 | 0.090 |
Why?
|
Jugular Veins | 2 | 2008 | 204 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2017 | 2453 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2016 | 2373 | 0.090 |
Why?
|
Cross-Sectional Studies | 6 | 2014 | 25043 | 0.080 |
Why?
|
Radial Artery | 2 | 2008 | 194 | 0.080 |
Why?
|
Clinical Protocols | 1 | 2015 | 1462 | 0.080 |
Why?
|
Hospital-Patient Relations | 1 | 2008 | 16 | 0.080 |
Why?
|
Laboratories | 1 | 2012 | 463 | 0.080 |
Why?
|
Immunity | 1 | 2015 | 1012 | 0.080 |
Why?
|
Pulmonary Ventilation | 2 | 2007 | 373 | 0.080 |
Why?
|
Hemodiafiltration | 1 | 2008 | 20 | 0.080 |
Why?
|
Poverty | 1 | 2020 | 2660 | 0.080 |
Why?
|
Decision Making, Computer-Assisted | 1 | 2008 | 150 | 0.080 |
Why?
|
Heart Rate | 3 | 2015 | 4091 | 0.080 |
Why?
|
Students | 1 | 2018 | 1654 | 0.080 |
Why?
|
Neoplasms | 4 | 2018 | 21683 | 0.080 |
Why?
|
Young Adult | 10 | 2020 | 56430 | 0.080 |
Why?
|
Medical Records | 1 | 2013 | 1413 | 0.080 |
Why?
|
Acclimatization | 1 | 2007 | 103 | 0.080 |
Why?
|
Decision Making | 2 | 2014 | 3887 | 0.080 |
Why?
|
Baroreflex | 1 | 2008 | 146 | 0.070 |
Why?
|
Demography | 1 | 2012 | 1656 | 0.070 |
Why?
|
Attitude to Death | 1 | 2010 | 382 | 0.070 |
Why?
|
Patient Rights | 1 | 2007 | 126 | 0.070 |
Why?
|
Hematinics | 1 | 2010 | 281 | 0.070 |
Why?
|
Diuretics | 3 | 2015 | 592 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2133 | 0.070 |
Why?
|
Environmental Exposure | 2 | 2018 | 4234 | 0.070 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39050 | 0.070 |
Why?
|
Altitude | 1 | 2007 | 161 | 0.070 |
Why?
|
Nursing Staff, Hospital | 1 | 2010 | 346 | 0.070 |
Why?
|
Cause of Death | 3 | 2017 | 3584 | 0.070 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2012 | 719 | 0.070 |
Why?
|
Observation | 1 | 2008 | 312 | 0.070 |
Why?
|
Skin Diseases | 1 | 2015 | 1065 | 0.070 |
Why?
|
Acute Disease | 3 | 2012 | 7149 | 0.070 |
Why?
|
Pancreatitis | 1 | 2013 | 1092 | 0.070 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 253 | 0.070 |
Why?
|
Heart Ventricles | 1 | 2018 | 3821 | 0.070 |
Why?
|
User-Computer Interface | 1 | 2013 | 1431 | 0.070 |
Why?
|
Health Promotion | 1 | 2018 | 2205 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2019 | 9959 | 0.070 |
Why?
|
Hyperoxia | 1 | 2007 | 262 | 0.070 |
Why?
|
Erythropoietin | 1 | 2010 | 726 | 0.060 |
Why?
|
Predictive Value of Tests | 7 | 2016 | 15076 | 0.060 |
Why?
|
Valproic Acid | 1 | 2008 | 445 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 1876 | 0.060 |
Why?
|
Dermatology | 1 | 2015 | 872 | 0.060 |
Why?
|
Anemia | 1 | 2014 | 1506 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2015 | 2716 | 0.060 |
Why?
|
Prevalence | 4 | 2016 | 15226 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1721 | 0.060 |
Why?
|
Health Care Rationing | 1 | 2007 | 437 | 0.060 |
Why?
|
Antimanic Agents | 1 | 2008 | 522 | 0.060 |
Why?
|
Adenoviridae | 2 | 1998 | 1099 | 0.060 |
Why?
|
Survival Analysis | 2 | 2018 | 10252 | 0.060 |
Why?
|
Brazil | 2 | 2018 | 1270 | 0.060 |
Why?
|
Computer Simulation | 2 | 2016 | 6196 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.060 |
Why?
|
Periodicals as Topic | 1 | 2014 | 1432 | 0.060 |
Why?
|
Leg Ulcer | 1 | 2003 | 69 | 0.060 |
Why?
|
Oxygen | 3 | 2012 | 4189 | 0.060 |
Why?
|
Massachusetts | 1 | 2016 | 8663 | 0.060 |
Why?
|
Gram-Positive Bacteria | 1 | 2014 | 184 | 0.060 |
Why?
|
Disease Progression | 2 | 2017 | 13284 | 0.060 |
Why?
|
Air Pollutants | 1 | 2017 | 2817 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12354 | 0.050 |
Why?
|
Ventricular Function, Left | 1 | 2015 | 3670 | 0.050 |
Why?
|
Pyoderma Gangrenosum | 1 | 2003 | 76 | 0.050 |
Why?
|
Developing Countries | 1 | 2015 | 2815 | 0.050 |
Why?
|
Neutrophils | 1 | 2015 | 3719 | 0.050 |
Why?
|
Clinical Competence | 1 | 2018 | 4687 | 0.050 |
Why?
|
Echinocandins | 1 | 2011 | 45 | 0.050 |
Why?
|
Prospective Studies | 5 | 2019 | 53288 | 0.050 |
Why?
|
Lipopeptides | 1 | 2011 | 75 | 0.050 |
Why?
|
Fluconazole | 1 | 2011 | 146 | 0.050 |
Why?
|
Blood Flow Velocity | 3 | 2010 | 1423 | 0.050 |
Why?
|
Models, Biological | 1 | 2017 | 9583 | 0.050 |
Why?
|
Homeostasis | 2 | 2008 | 3340 | 0.050 |
Why?
|
Leukocyte Count | 2 | 2015 | 1588 | 0.050 |
Why?
|
Employment | 1 | 2007 | 1132 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7913 | 0.040 |
Why?
|
Social Class | 2 | 2020 | 1999 | 0.040 |
Why?
|
European Union | 1 | 2020 | 158 | 0.040 |
Why?
|
Socioeconomic Factors | 2 | 2018 | 7785 | 0.040 |
Why?
|
Receptors, Vitronectin | 1 | 1998 | 52 | 0.040 |
Why?
|
Wavelet Analysis | 1 | 2018 | 57 | 0.040 |
Why?
|
Expert Systems | 1 | 2018 | 81 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 2020 | 139 | 0.040 |
Why?
|
Research Design | 1 | 2014 | 5987 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2010 | 2149 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2018 | 21746 | 0.040 |
Why?
|
Clinical Alarms | 1 | 2018 | 51 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.040 |
Why?
|
Candida albicans | 1 | 2011 | 394 | 0.040 |
Why?
|
Models, Organizational | 1 | 2001 | 574 | 0.040 |
Why?
|
Ultrasonography, Doppler, Transcranial | 2 | 2010 | 292 | 0.040 |
Why?
|
Receptors, Virus | 2 | 1998 | 648 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15295 | 0.040 |
Why?
|
Enterovirus | 1 | 1998 | 64 | 0.040 |
Why?
|
Therapeutics | 1 | 2018 | 116 | 0.040 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2014 | 687 | 0.040 |
Why?
|
Chronic Disease | 1 | 2012 | 9146 | 0.040 |
Why?
|
Spain | 1 | 2018 | 465 | 0.040 |
Why?
|
Hospitalists | 1 | 2001 | 305 | 0.040 |
Why?
|
Taiwan | 1 | 2018 | 496 | 0.040 |
Why?
|
Clinical Coding | 1 | 2018 | 171 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2011 | 730 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5751 | 0.030 |
Why?
|
Medically Underserved Area | 1 | 2018 | 253 | 0.030 |
Why?
|
Greece | 1 | 2016 | 344 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2759 | 0.030 |
Why?
|
Colombia | 1 | 2016 | 258 | 0.030 |
Why?
|
Overweight | 2 | 2019 | 2371 | 0.030 |
Why?
|
England | 1 | 2017 | 522 | 0.030 |
Why?
|
Risk | 2 | 2020 | 9687 | 0.030 |
Why?
|
State Medicine | 1 | 2017 | 217 | 0.030 |
Why?
|
Programming Languages | 1 | 2016 | 133 | 0.030 |
Why?
|
Mongolia | 1 | 2015 | 91 | 0.030 |
Why?
|
Thinness | 1 | 2019 | 480 | 0.030 |
Why?
|
Hypertension | 1 | 2015 | 8480 | 0.030 |
Why?
|
Pregnancy | 1 | 2017 | 29144 | 0.030 |
Why?
|
Inflammation | 1 | 2015 | 10638 | 0.030 |
Why?
|
Cities | 1 | 2017 | 513 | 0.030 |
Why?
|
Pancreas, Artificial | 1 | 2015 | 54 | 0.030 |
Why?
|
Mexico | 1 | 2016 | 690 | 0.030 |
Why?
|
Death | 1 | 2019 | 678 | 0.030 |
Why?
|
Respiratory Mechanics | 2 | 2008 | 686 | 0.030 |
Why?
|
Incidence | 3 | 2020 | 20947 | 0.030 |
Why?
|
Acid-Base Imbalance | 1 | 2013 | 41 | 0.030 |
Why?
|
Rural Health | 1 | 2015 | 305 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 764 | 0.030 |
Why?
|
Microscopy | 1 | 2018 | 903 | 0.030 |
Why?
|
Diffusion of Innovation | 1 | 2018 | 725 | 0.030 |
Why?
|
Adolescent | 4 | 2020 | 85781 | 0.030 |
Why?
|
Focus Groups | 1 | 2018 | 1321 | 0.030 |
Why?
|
Hospital Bed Capacity | 1 | 2014 | 214 | 0.030 |
Why?
|
Commerce | 1 | 2018 | 592 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2016 | 634 | 0.030 |
Why?
|
Ethics, Medical | 1 | 2018 | 792 | 0.030 |
Why?
|
Uganda | 1 | 2016 | 1243 | 0.030 |
Why?
|
Program Development | 1 | 2018 | 1316 | 0.030 |
Why?
|
International Cooperation | 1 | 2018 | 1420 | 0.020 |
Why?
|
Brain | 2 | 2008 | 26385 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1011 | 0.020 |
Why?
|
Perception | 1 | 2018 | 1198 | 0.020 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2012 | 236 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2018 | 1534 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2016 | 921 | 0.020 |
Why?
|
Patient Selection | 2 | 2016 | 4215 | 0.020 |
Why?
|
Platelet Count | 1 | 2013 | 781 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2018 | 14722 | 0.020 |
Why?
|
Intubation, Intratracheal | 1 | 2019 | 1364 | 0.020 |
Why?
|
Monte Carlo Method | 1 | 2016 | 1254 | 0.020 |
Why?
|
Nursing Methodology Research | 1 | 2010 | 67 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6487 | 0.020 |
Why?
|
Visitors to Patients | 1 | 2010 | 35 | 0.020 |
Why?
|
Polypharmacy | 1 | 2013 | 294 | 0.020 |
Why?
|
Geriatric Nursing | 1 | 2010 | 39 | 0.020 |
Why?
|
gamma-Glutamyltransferase | 1 | 2010 | 134 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3870 | 0.020 |
Why?
|
Dyspnea | 1 | 2017 | 1303 | 0.020 |
Why?
|
Phosphates | 1 | 2013 | 786 | 0.020 |
Why?
|
Genetic Vectors | 1 | 1998 | 3420 | 0.020 |
Why?
|
Natriuretic Peptide, C-Type | 1 | 2008 | 23 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2309 | 0.020 |
Why?
|
Muscle Tonus | 1 | 2008 | 81 | 0.020 |
Why?
|
Leadership | 1 | 2018 | 1357 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6489 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2015 | 2715 | 0.020 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1213 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
Patient Advocacy | 1 | 2010 | 353 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11725 | 0.020 |
Why?
|
Delirium | 1 | 2018 | 1609 | 0.020 |
Why?
|
Cerebral Veins | 1 | 2008 | 156 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2010 | 865 | 0.020 |
Why?
|
Temperature | 1 | 2012 | 2206 | 0.020 |
Why?
|
Blood Transfusion | 1 | 2012 | 1301 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2014 | 7181 | 0.020 |
Why?
|
Placebo Effect | 1 | 2010 | 502 | 0.020 |
Why?
|
Respiration | 1 | 2012 | 1653 | 0.020 |
Why?
|
Cerebral Arteries | 1 | 2008 | 494 | 0.020 |
Why?
|
Inpatients | 1 | 2017 | 2518 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2170 | 0.020 |
Why?
|
Down-Regulation | 1 | 2013 | 3002 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2013 | 1584 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2010 | 721 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 1919 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2015 | 2708 | 0.010 |
Why?
|
Models, Cardiovascular | 1 | 2008 | 996 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8089 | 0.010 |
Why?
|
Linear Models | 1 | 2013 | 5952 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7322 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1504 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4933 | 0.010 |
Why?
|
Electrocardiography | 1 | 2015 | 6442 | 0.010 |
Why?
|
Qualitative Research | 1 | 2010 | 2682 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 1998 | 5181 | 0.010 |
Why?
|
Adenovirus E2 Proteins | 1 | 1998 | 8 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2008 | 2132 | 0.010 |
Why?
|
Family | 1 | 2010 | 3147 | 0.010 |
Why?
|
Thymidine Kinase | 1 | 1998 | 290 | 0.010 |
Why?
|
Ganciclovir | 1 | 1998 | 258 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 1998 | 573 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 898 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2010 | 12026 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 1998 | 913 | 0.010 |
Why?
|
Gene Expression | 2 | 1998 | 7799 | 0.010 |
Why?
|
CHO Cells | 1 | 1998 | 1406 | 0.010 |
Why?
|
Genes, Reporter | 1 | 1998 | 1547 | 0.010 |
Why?
|
Substrate Specificity | 1 | 1998 | 1801 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1998 | 2050 | 0.010 |
Why?
|
Integrins | 1 | 1998 | 846 | 0.010 |
Why?
|
Mucin-1 | 1 | 1998 | 543 | 0.010 |
Why?
|
Cricetinae | 1 | 1998 | 2472 | 0.010 |
Why?
|
Tissue Distribution | 1 | 1998 | 2327 | 0.010 |
Why?
|
Species Specificity | 1 | 1998 | 2478 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2839 | 0.010 |
Why?
|
Quality of Life | 1 | 2014 | 12804 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 1998 | 1224 | 0.010 |
Why?
|
DNA, Viral | 1 | 1998 | 2225 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4320 | 0.010 |
Why?
|
Leukocytes, Mononuclear | 1 | 1998 | 1836 | 0.010 |
Why?
|
Cell Division | 1 | 1998 | 4568 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2008 | 5027 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1998 | 6314 | 0.010 |
Why?
|
Transfection | 1 | 1998 | 5892 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2003 | 12959 | 0.000 |
Why?
|
Hematopoietic Stem Cells | 1 | 1998 | 3386 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13815 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 18111 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1998 | 13033 | 0.000 |
Why?
|
Mice | 1 | 1998 | 81183 | 0.000 |
Why?
|
Animals | 1 | 1998 | 168757 | 0.000 |
Why?
|